Clinical Trial Update: Fycompa in Subjects With Small Fiber Neuropathy (SFN) [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of Fycompa (perampanel) in subjects with small fiber neuropathy, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Fiber Neuropathy

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: PNA Center for Neurological Research | Conditions: Neuropathy, Small Fiber | Phase 2 | Status: UNKNOWN